Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Structured Opioid Discontinuation in CLBP
NCT02741076Phase 4Terminated
- Sponsor
- Opioid PMR Consortium
- Start
- Sep 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of morphine, oxycodone and oxymorphone in chronic low back pain (CLBP) (4 arms), sponsored by Opioid PMR Consortium. Primary endpoint: Change in Mean Average Pain Intensity Score on the NRS at 12 weeks. Started Sep 2016; status: terminated.
02
Drugs
morphineoxycodoneoxymorphone
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT02741076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02741076.